© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Formulary
PBMs are Creating GPOs, and Stirring Debate as to Why
July 12, 2022
The Big Three all set up group purchasing organizations recently, but some industry observers question the timing of the move and who will benefit.
Specialty Pharmacy Has Won Lawsuit Against CVS Caremark
July 06, 2022
The case concerns the controversial direct and indirect remuneration (DIR) fees that pharmacy benefit managers (PBMs) collect from pharmacies. Meanwhile, a separate whistleblower lawsuit has been filed against CVS Caremark, its parent company and SilverScripts, its Part D plan, accusing them of blocking customers from getting cheaper generic drugs.
Researchers to Medicare: Mark Cuban Prices Could Have Saved You $3.6 Billion
June 24, 2022
Harvard researchers calculated that buying 77 generic drugs at prices being charged by Mark Cuban’s online pharmacy prices would have lowered Medicare spending on those drugs from $9.6 billion to $6 billion.
CVS Caremark Puts Eliquis Back On Its Formularies
June 24, 2022
The American College of Cardiology and patient groups pushed the PBM to reverse its decision to take Eliquis off its formularies. CVS Caremark says it changed course after negotiating a lower net price.
Please Take Our Annual Pharmacy Survey! Five Minutes, Tops.
June 23, 2022
Respondents can win a $250 gift card.
A Surge of Biologics for Severe Asthma
June 21, 2022
Six biologics are on the market and more are in the pipeline. Biologics target the inflammatory cytokines involved in the pathogenesis of asthma.
Aduhelm: Great Expectations Fizzle
June 17, 2022
Dogged by controversy, the new Alzheimer’s drug has not fared well since its approval by the FDA a year ago.
Enbrel Stays Above the Biosimilar Fray, but Humira Biosimilars May Nip at its Heels
June 15, 2022
Amgen’s biologic won’t have biosimilar competition till 2029. But the possibility that up to 11 Humira biosimilars may come on the market in 2023 could exert some downward pressure on Enbrel’s price.
CDC’s Proposed Opioid Prescribing Guideline: Does it Fall Short on Drug Testing?
April 18, 2022
Last month, the Centers for Disease Control and Prevention shared a draft update to its Clinical Practice Guideline for Prescribing Opioids. The proposed revision comes as the nation’s overdose death rate reaches an all-time high, fueled largely by the economic and psychological strains and lack of healthcare access caused by COVID-19.
Large Employers Launch PBM
February 23, 2022
EmsanaRx, a pharmacy benefit manager launched by the Purchaser Business Group on Health, started operations in January.